State Secretary Blokhuis: boys will also be vaccinated against HPV virus The vaccine against the HPV human papillomavirus virus will also become available for boys.
A guide for the safe reuse of diaper and incontinence materials RIVM has developed a step-by-step plan for the safe reuse of diapers and incontinence material. This plan provides recyclers and licensing authorities with tools to carry out a risk assessment.
New data on greenhouse gas and ammonia emissions Greenhouse gas emissions have fallen slightly; ammonia emissions remain stable.
Humans themselves are the most important source of ESBL Antibiotic Resistance Human to human transfer is the main source of ESBL (Extended Spectrum Beta-Lactamase) antibiotic resistance, according to researchers from the ESBLAT research consortium, of which RIVM is a member.
Medication may affect diagnostic tests The use of medication may affect diagnostic tests. This may distort the results of those tests.
Mild 2018-2019 influenza epidemic The annual influenza epidemic in the winter of 2018-2019 was less severe than the year before. Approximately 400,000 people have had the flu.
WHO Chemical Risk Assessment Workshop on new and emerging risks to human health from chemicals RIVM is hosting an international workshop on new and emerging risks from chemicals on 20 and 21 February 2019.
Possible health risks due to exposure to chromium-6 at tROM project Tilburg Research by RIVM shows that the participants in the so-called tROM project, their supervisors and other people involved may have been exposed to chromium-6.
Kick off European Project VITAL: Vaccines and InfecTious diseases in the Ageing popuLation Recently, the EU-sponsored Vaccines and InfecTious diseases in the Ageing popuLation (VITAL) project was launched.
National Agreement leads to small improvement in intake of salt and sugar RIVM calculations show that only small steps have been taken to reduce daily salt and energy intake (via sugar) within the National Agreement to Improve Product Composition.